Member of AWS' global healthcare leadership team, in this role co-developed international strategy with a focus on optimizing data utilization across public sector healthcare, established/ lead AWS global healthcare AI, analytics and data team that accelerates customer adoption of data, AI and Generative AI, driving patient benefit and commercial outcomes, established/lead international program team, driving complex cross-AWS programs requiring multi-organisation delivery, spanning engineering, professional services, business development and field sales; and support new product development, working cross-AWS to innovate new products, solutions, and cloud services to meet customer needs. Recent projects include applying Generative AI for healthcare information synthesis and retrieval, utilizing multimodal AI for cancer research by harnessing genomic and imaging data, automating patient referral triage using Machine Learning models, pan-AWS delivery of Trusted Research Environments for healthcare and research data capabilities, population-scale applications of large language models, and healthcare data strategy for leading institutions.

Commercial and technology consulting leader for cross sector AI/data science, spanning strategy, prototyping & proof of concept/value, implementation and integration. UK AI Innovation leader, managing annual budget in excess of £1m. Led teams including consultants, data scientists and data engineers combining technologies across the AI ecosystem to develop best in class strategies and solutions to deliver measurable business outcomes. Developed UK-wide AI innovation strategy, supporting across all Deloitte UK verticals. Projects included AI costumer contact management, AI Assistants/Chatbots to improve customer engagement/internal self service, AI referral triage, industries included financial services, healthcare, telco legal and retail. Worked with technologies across the AI ecosystem, including major tech such as Google GCP, AWS, IBM Watson, and start-ups.

Led European technology strategy development, presales cycle and projects for clients seeking to implement enterprise artificial intelligence across business'. Built and led high performing European commercial team resulting in significant multi$m deals across Europe. Example projects include clinical decision support, cognitive health and wellness applications, scientific research technologies and data repositories. Identified new artificial intelligence opportunities, academic partners and support development of long term implementation roadmapsDelivered thought leadership and market shaping activities

Delivered world class strategy projects for a broad range of international clients, focused on the application of digital, novel technology and data analytics. Member of UK leadership team with project and direct reports. Experience of a wide range of technology approaches, including Agile Led design, development, implementation and management of Deloitte Oncology Analytics Solution: highly secure scalable integration and reporting platform integrating sensitive data across public and private stakeholders to deliver business model transformation, initially for Healthcare and Life Sciences clients in Oncology area Delivered multi-year, pan-European strategy programme for Global Head of Pricing & Market Access at top-5 Pharmaceutical Company to develop digital commercial models linking price to patient outcomes Part of Deloitte’s ‘Insight Driven Organisation’ team, including design and execution of ideation and innovation workshops to demonstrate Deloitte capabilities using client data

Lead strategy consulting teams supporting global pharmaceutical & biotechnology companiesRecent projects include:- Cross divisional business capability development, including technology requirements - Emerging market medical device portfolio strategy, including identification of local licensing and acquisition targets- Supply chain product flow analysis and reporting- Emerging market pharmaceutical strategy, including organisational and portfolio approach- Emerging market risk analysis & distribution model development- Cross-franchise European medical devices strategy

Consulted to pharmaceutical companies based in North America and Europe. Projects included novel oncology technology strategy, regulatory affairs operating model design, clinical process development and assessment of in-licensing opportunities in India. Supported Kinapse CEO and COO in expanding UK business and developing India-based analyst team

Life Science Management Consultant

Life Science Management Consultant

Maintained global development plans, supporting all line functions, across preclinical and exploratory development respiratory portfolio Successfully drove multiple drug discovery projects through key project milestones, including preclinical proof of principle, toxicology, first in man and clinical proof of concept Developed respiratory project and portfolio tracking and reporting process, working closely with research team leaders & global line functions.

Led internal proteomic technology projects and managed research assistants to identify and develop novel technology applications and opportunities. Supported due diligence process with financial institutions and potential co-development partners.Part of Discovery Net project team applying Grid technologies to biological research. This project was awarded “Most Innovative Data Intensive Application” at the 2003 Super Computing conference.

Thesis title: “Molecular characterisation of Endo180, a novel recycling transmembrane receptor”Ph.D. published in leading journals as: Howard, M., and Isacke, C.M. (2002). The C-type lectin receptor Endo180 displays internalization and recycling properties distinct from other members of the mannose receptor family. J Biol Chem 277, 32320-32331Howard, M., Chambers, M., Mason, R., and Isacke, C.M. (2004). Distribution of Endo180 receptor and ligand in developing articular cartilage. Osteoarthritis and Cartilage 12, 74-82Bailey, L., Wienke, D., Howard, M., Knauper, V., Isacke, C.M., and Murphy, G. (2002). Investigation of the role of Endo180/urokinase-type plasminogen activator receptor-associated protein as a collagenase 3 receptor. Biochem J 363 67-72